Back to Search Start Over

Supplementary Figure 1 from Efficacy of Low-Dose Oral Metronomic Dosing of the Prodrug of Gemcitabine, LY2334737, in Human Tumor Xenografts

Authors :
Anne H. Dantzig
Everett J. Perkins
Enaksha R. Wickremsinhe
James J. Starling
Gregory P. Donoho
Robert L. Shepard
Sara Durland–Busbice
Susan E. Pratt
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

PDF file - 316K, Supplementary Figure 1 - in vivo study body weights

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....71b531576d023873277f8bbc6e15fa91
Full Text :
https://doi.org/10.1158/1535-7163.22498851